Searching... Searching...
  • NVP + NA
  • Köp NA
  • Sälj NA
  • Senast NA
  • SEK

  • NEVPF +NA
  • Buy NA
  • Sell NA
  • Latest NA
  • USD

Our Projects

Our Projects

We develop treatments for mitochondrial diseases that lack adequate treatment

Read More

Our Strategy

Our Strategy

Our goal at Abliva is to translate mitochondrial science to clinical practice

Read More

Our People

Our People

The team at Abliva is driven by the passion to make health care better

Read More

Our Partners

Our Partners

Abliva works with international organizations in academia and industry

Read More

Abliva's focus is on developing drug candidates that maintain mitochondrial integrity and improves their function.

  • Press Releases

    Magnus Persson leaves the Board of Directors of Abliva AB to focus on role as founding partner at Eir Ventures 08 October Abliva AB (Nasdaq Stockholm: ABLI) today announces that M... Read More

Focusing on primary mitochondrial disorders

Abliva focuses on developing drug candidates that maintain mitochondrial integrity and improve their function

Read More